T 0189/01 (IFN-beta 2/IL-6R/YEDA RESEARCH AND DEVELOPMENT CO., LTD.) of 15.06.2004
- European Case Law Identifier
- ECLI:EP:BA:2004:T018901.20040615
- Date of decision
- 15 June 2004
- Case number
- T 0189/01
- Petition for review of
- -
- Application number
- 90110487.7
- IPC class
- C12P 21/02
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it
- Applicant name
- YEDA RESEARCH AND DEVELOPMENT COMPANY LIMITED
- Opponent name
- Chugai Pharmaceutical Co., Ltd.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 114(2) 1973European Patent Convention Art 123(2) 1973European Patent Convention Art 56 1973European Patent Convention Art 83 1973European Patent Convention R 88 1973
- Keywords
- G 0009/91, G 0001/92, G 0001/03, T 0952/92, T 0728/98
- Catchword
- -
- Cited cases
- -
ORDER
For these reasons it is decided that:
1. The request of appellant I (patentee) pursuant to Rule 88 EPC to amend claim 9 of the patent as maintained by the opposition division by the insertion of "or" before "for a protein" is allowed.
2. The respective appeals of appellant I (patentee) and appellant II (opponent) are dismissed.